Balance Improvement Intervention for Vestibular Hypofunction
(MINDGAPS Trial)
Trial Summary
What is the purpose of this trial?
The proposed research is relevant to vestibular science and the general public because age-related vestibular hypofunction is a major contributor to poor balance, falls, and other adverse health outcomes. In this investigation the investigators will: 1) assess the preliminary efficacy of a novel intervention system for improving vestibular function and dizziness in community-dwelling older adults, 2) assess the safety and feasibility of the this system, and 3) assess the acceptability and implementation potential of this system, prior to a large-scale, R01-level investigation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Novel Intervention System for improving balance in patients with vestibular hypofunction?
Research shows that vestibular rehabilitation therapy, which is similar to the Novel Intervention System, can help reduce fall risk and improve balance in people with vestibular issues. This suggests that the Novel Intervention System might also be effective in improving balance for those with vestibular hypofunction.12345
Is the Balance Improvement Intervention for Vestibular Hypofunction safe for humans?
The research articles focus on the effectiveness of vestibular rehabilitation and related interventions, but they do not provide specific safety data. However, these studies generally imply that such interventions are safe, as they are commonly used in clinical settings for balance improvement.13567
How is the Balance Improvement Intervention for Vestibular Hypofunction treatment different from other treatments?
Eligibility Criteria
This trial is for older adults who can stand on their own and have dizziness or balance problems due to vestibular hypofunction, confirmed by specific tests. It's not for those with blindness, neck spine disorders, certain artery issues, or eye movement problems caused by central nervous system dysfunction.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants undergo baseline assessments to establish control measures before intervention
Treatment
Participants complete 6 weeks of individualized vestibular rehabilitation informed by the MINDGAPS system
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Novel Intervention System
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Montana
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Johns Hopkins University
Collaborator